Chinese english Germany Japanese Korea

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)-

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)- Struktur
1037559-82-2
CAS-Nr.
1037559-82-2
Englisch Name:
3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)-
Synonyma:
PF-07321332 Impurity 90;Nirmatrelvir Impurity 60;(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carbonitrile;3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)-
CBNumber:
CB68348658
Summenformel:
C8H12N2
Molgewicht:
136.19
MOL-Datei:
1037559-82-2.mol
Request For Quotation

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)- Eigenschaften

Siedepunkt:
233.5±23.0 °C(Predicted)
Dichte
1.06±0.1 g/cm3(Predicted)
pka
7.76±0.60(Predicted)

Sicherheit

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

3-Azabicyclo[3.1.0]hexan-2-one,6,6-dimethyl-,(1R-cis)-(9CI) 3-Azabicyclo[3.1.0]hex-2-ene, 6,6-dimethyl-, (1R,5S)- sodium:cyanide

Downstream Produkte

3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8043 55
QUALITY CONTROL SOLUTIONS LTD. 13670046396
 ORDERS@QCSRM.COM China 18820 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-8210725 4008210725
 malulu@leyan.com China 40036 58
  • 3-Azabicyclo[3.1.0]hexane-2-carbonitrile, 6,6-dimethyl-, (1R,2S,5S)-
  • (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carbonitrile
  • PF-07321332 Impurity 90
  • Nirmatrelvir Impurity 60
  • 1037559-82-2
Copyright 2019 © ChemicalBook. All rights reserved